The 1 analysts offering 12-month price forecasts for Hepion Pharmaceuticals Inc have a median target of 8.00, with a high estimate of 8.00 and a low estimate of 8.00. The median estimate represents a +247.83% increase from the last price of 2.30.
The current consensus among 1 polled investment analysts is to Buy stock in Hepion Pharmaceuticals Inc. This rating has held steady since December, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.20
Reporting Date Mar 03
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.